Crescent Capital BDC, Inc. (CCAP) - 2019 Annual Report Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2019. Crescent Capital BDC, Inc. is an externally managed, closed-end, non-diversified management investment company organized as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The Company invests primarily in secured and unsecured debt and related equity securities of private U.S. middle-market companies. A significant development occurring immediately after the reporting period was the completion of the acquisition of Alcentra Capital Corporation on January 31, 2020, and the subsequent listing of the Company's common stock on the NASDAQ under the symbol "CCAP" on February 3, 2020.
Key Financial Metrics
| Metric | 2019 | 2018 |
|---|---|---|
| Total Investment Income | $53.5 million | $33.3 million |
| Net Investment Income | $31.7 million | $17.7 million |
| Net Realized and Unrealized Gains (Losses) | ($2.2 million) | ($9.5 million) |
| Net Increase in Net Assets from Operations | $29.3 million | $8.1 million |
| Total Assets | $747.2 million | $505.4 million |
| Total Debt (Carrying Value) | $322.0 million | $235.7 million |
| Net Assets | $406.9 million | $259.6 million |
| Net Asset Value (NAV) per Share | $19.50 | $19.43 |
| Asset Coverage Ratio | 225% | 208% |
| Weighted Average Yield (Debt Investments) | 8.4% | 9.0% |
| Dividends Declared per Share | $1.64 | $1.47 |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased by approximately 47% to $726.5 million, driven by new originations and the expansion of the Senior Loan Fund.
- Income Growth: Net investment income increased 79% year-over-year, primarily due to a larger portfolio size and increased dividend income from equity co-investments.
- Expense Increases: Total expenses rose to $30.9 million (net of waivers: $21.7 million) compared to $20.2 million (net of waivers: $15.4 million) in 2018. Interest and debt financing costs increased to $13.4 million due to higher average debt outstanding ($275.9 million vs. $182.3 million).
- Fee Waivers: The Advisor waived the entire income incentive fee for 2019 ($4.75 million) and a portion of the management fee ($4.5 million) in exchange for extending the capital commitment period and facilitating the Alcentra Acquisition.
- Debt Facilities: The Company terminated its Revolving Credit Facility II in August 2019 and entered into a new $200 million Corporate Revolving Facility. The SPV Asset Facility was increased to $250 million.
Guidance, Outlook, and Risks
Recent Developments and Outlook: Following the reporting period, the Company completed the acquisition of Alcentra Capital, significantly expanding its asset base. In connection with this transaction, the Investment Advisory Agreement was amended to permanently reduce the base management fee from 1.50% to 1.25% and waive a portion of the fee through July 2021. The income incentive fee hurdle was increased from 6% to 7% annualized, and the income-based incentive fee was waived through July 2021. The Company also initiated a $20 million share repurchase program effective March 2020.
Key Risks and Contingencies:
- LIBOR Discontinuation: The Company faces uncertainty regarding the future of LIBOR, which may impact the valuation of its floating-rate portfolio and cost of capital.
- Leverage and Asset Coverage: The Company operates with significant leverage. While the asset coverage ratio was 225% at year-end, a decline in asset values could restrict borrowing or distributions. The Board approved a reduction in the required asset coverage ratio from 200% to 150%, effective March 2021 (subject to shareholder approval).
- Valuation Uncertainty: A significant portion of the portfolio consists of Level 3 assets (illiquid private debt), requiring fair value determination by the Board, which introduces estimation risk.
- Legal Proceedings: The Company assumed certain litigation from Alcentra Capital regarding the merger transaction, though management believes the claims are without merit.
Investor Verification Checklist
- Verify the final purchase price allocation and pro forma financial impact of the Alcentra Capital acquisition.
- Confirm the status of the shareholder vote regarding the reduction of the asset coverage ratio to 150%.
- Monitor the execution of the $20 million share repurchase program and its impact on NAV.
- Review the composition of the portfolio for exposure to LIBOR-indexed assets and the Company's transition plan to alternative reference rates (e.g., SOFR).
- Assess the sustainability of the dividend payout ratio given the waiver of incentive fees and the potential for increased expenses post-acquisition integration.